Skip to content

NAGE NAGE Contract Liabilities

Contract Liabilities at other companies

Biote Corp. logo
Biote Corp.BTMD
$922K-36.4%
USANA Health Sciences logo
USANA Health SciencesUSNA
$10.32M-14.6%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$3.2M-8.6%
CVR Partners logo
CVR PartnersUAN
$19.03M-25.0%

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's contract liabilities?
NAGE (NAGE) reported contract liabilities of $2.57M in Q1 2026.
How has NAGE's contract liabilities changed year-over-year?
NAGE's contract liabilities decreased by 0.3% year-over-year, from $2.58M to $2.57M.
What is the long-term trend for NAGE's contract liabilities?
Over 4 years (2021 to 2025), NAGE's contract liabilities has grown at a -11.4% compound annual growth rate (CAGR), from $4.35M to $2.67M.
What does contract liabilities mean?
Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.